Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTENT study of continuous versus intermittent infusion antibiotics for infective endocarditis
2013-002807-32Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2013
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of benzylpenicillin and dicloxacillin in endocarditis (IE) (2 arms), sponsored by Aarhus University Hospital. Started Sep 2013; status: terminated.
02
Drugs
benzylpenicillindicloxacillin
03
Conditions
endocarditis (IE)
Beyond the preview
Go deeper on 2013-002807-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002807-32.